
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[MRNA] Moderna Inc - Investing Cash Flow / Sales
Data updated 2023-Sep-23 (Saturday)Note: Detailed Statistics for Investing Cash Flow / Sales in Cashflow Statement for Moderna Inc [NASDAQ:MRNA] with frequency distribution chart that analyze trends & history . Investing Cash Flow / Sales or Revenue is expressed as a % for period. View Cashflow Statement for broader context
Share
Quarterly Investing Cash Flow / Sales values for Moderna Inc are rounded to enhance readability
2023-Jun | 2023-Mar | 2022-Dec | 2022-Sep | 2022-Jun | 2022-Mar | |
---|---|---|---|---|---|---|
Investing Cash Flow / Sales | 565.1% | 107.5% | -20.9% | 28.5% | -24.4% | -64.8% |
Sequential Quarter Growth | +425.5% | +615.5% | -173.1% | +216.8% | +62.3% | -306.7% |
Quarter-on Quarter Growth | +2,415.1% | +266.0% | -31.0% | +142.6% | +72.6% | -597.4% |
Annual Investing Cash Flow / Sales values for Moderna Inc are rounded to enhance readability
2022-Dec | 2022-Jan | 2021-Jan | 2020-Jan | 2019-Jan | 2018-Jan | |
---|---|---|---|---|---|---|
Investing Cash Flow / Sales | -27.1% | -26.9% | -46.3% | -208.2% | -25.0% | -275.6% |
Year-on-Year Growth | -0.8% | +42.0% | +77.8% | -732.9% | +90.9% | -171.8% |
2-yr CAGR | ||||||
3-yr CAGR | ||||||
4-yr CAGR | ||||||
5-yr CAGR |
Frequency distribution of quarterly Investing Cash Flow / Sales values from 2017-Dec-31 grouped into buckets. Latest Investing Cash Flow / Sales value is 565 as of 2023-Jun-30
Subsequent stock performance post earnings date till next announcement for Moderna Inc mapped with quarterly Investing Cash Flow / Sales values reported at that time. Most recent value denoted with star
Select frequency and calculation type for Investing Cash Flow / Sales above for vertical axis in scatter chart. Additionally choose type of performance for horizontal axis
Bayesian (Conditional Probability) analysis for Moderna Inc with subsequent post-earnings performance given Investing Cash Flow / Sales values. Analysis uses quarterly data and subsequent relative performance benchmarked to S&P 500 index. Most recent quarter is denoted with a star and corresponding partial performance is excluded from calculations
Underperform (relative perf.) | Outperform (relative perf.) | |
---|---|---|
Investing Cash Flow / Sales - Low | 45% | 55% |
Investing Cash Flow / Sales - Medium | 69% | 31% |
Investing Cash Flow / Sales - High | 53% | 47% |
Investing Cash Flow / Sales (Sequential growth %) - Low | 74% | 26% |
Investing Cash Flow / Sales (Sequential growth %) - Medium | 36% | 64% |
Investing Cash Flow / Sales (Sequential growth %) - High | 53% | 47% |
Investing Cash Flow / Sales (QoQ growth %) - Low | 85% | 15% |
Investing Cash Flow / Sales (QoQ growth %) - Medium | 53% | 47% |
Investing Cash Flow / Sales (QoQ growth %) - High | 18% | 82% |
Related to Moderna Inc
Information for Moderna Inc
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Sep-12 on Google
SEC Reports : Quarterly reports around 2025-Sep-12 on SEC Edgar
Compare Moderna Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Moderna Inc
Industry : Biotechnology industry performance which includes Moderna Inc